Recent News

For University of Vermont-related news, see below. For MaineHealth news, click here.

  • Cullen & Weston Research on Autism Spectrum Disorder Mentioned in Chip Chick
    November 8, 2022 by Lucy Gardner Carson
    (NOVEMBER 8, 2022) Research on autism spectrum disorder conducted by Neuroscience Graduate Program doctoral student Erin Cullen and Assistant Professor of Neurological Sciences Matthew Weston, Ph.D., in collaboration with researchers at Dartmouth’s medical school, was featured in Chip Chick. (Click on headline for more.)
  • Dittus, Sikorski Comment on UVM Cancer Center Being Named Health.com’s Innovative Hospital Award Winner for 2022
    November 8, 2022 by Lucy Gardner Carson
    (NOVEMBER 8, 2022) Medical oncologist Kim Dittus, M.D., Ph.D., associate professor of medicine and director of the UVM Cancer Center’s Steps to Wellness exercise program for cancer survivors, was interviewed for a story about the Cancer Center being named Health.com’s Innovative Hospital Award Winner for 2022. Also interviewed was cancer survivor Evelyn Sikorski, manager of UVMMC’s employee health and wellness and employee assistance programs.
    Read full story at Health.com
  • Press-Republican Covers Bell’s Facebook Live Event on RSV in Kids
    November 7, 2022 by Lucy Gardner Carson
    (NOVEMBER 7, 2022) Associate Professor of Pediatrics Rebecca Bell, M.D., answered RSV-related questions during a Facebook Live event on November 3, the (Plattsburg) Press-Republican reported.
  • Sigmon Warns of Xylazine-Laced Opioids in VTDigger Article
    November 7, 2022 by Lucy Gardner Carson
    (NOVEMBER 7, 2022) Stacey Sigmon, Ph.D., professor of psychiatry and director of the Center on Rural Addiction, was quoted in VTDigger discussing the increasing use of the animal sedative xylazine as a sought-after dilutant for opioids due to its effect of prolonging the “high” from using opioids.
  • Bertges Clinical Trial Mentioned in Cardiovascular Business News
    November 4, 2022 by Lucy Gardner Carson
    (NOVEMBER 4, 2022) Professor of Surgery and UVMMC vascular surgeon Daniel J. Bertges, M.D., presented a clinical trial on paclitaxel drug-coated balloons (DCBs) at the VIVA Foundation’s VIVA22 conference in Las Vegas, according to CardiovascularBusiness.com.

Want to be our next news story?

Have you started a cool new project? Published a paper? Won an award? We want to hear from you! Contact us to be highlighted on our website, in our newsletters, and/or in our press releases.

Check out our newsletter archive:

December 2021

March 2022

August 2022

SpecialEditionAug2022

June 2023

Fall 2023

Winter 2024

Spring 2024

Summer 2024

Fall 2024

Questions?

Please email us with any questions or for assistance accessing services.

Become a Member

All NNE-CTR members have access to our services and support. Learn more about the free benefits of membership, and join today!